HONG KONG – Singapore's Agency for Science, Technology and Research (A*STAR) has initiated the Pharma Innovation Programme Singapore (PIPS) aimed at bringing together the city-state's public sector research capabilities and major global players in the pharma industry to transform the manufacturing operations and technologies of the industry for greater efficiencies.